Frequency of positive polyanion antibody tests after COVID-19 vaccination

Quantitative analysis of COVID-19 pneumonia severity by CT pneumonia evaluation algorithm utilizing deep studying know-how and blood take a look at outcomes
Objective: To judge whether or not early chest computed tomography (CT) lesions quantified by a man-made intelligence (AI)-based business software program and blood take a look at values on the preliminary presentation can differentiate the severity of COVID-19 pneumonia.
Supplies and strategies: This retrospective research included 100 SARS-CoV-2-positive sufferers with delicate (n = 23), reasonable (n = 37) or extreme (n = 40) pneumonia categorized in response to the Japanese tips.
Univariate Kruskal-Wallis and multivariate ordinal logistic analyses have been used to look at whether or not CT parameters (opacity rating, quantity of opacity, % opacity, quantity of excessive opacity, % excessive opacity and imply HU whole on CT) in addition to blood take a look at parameters [procalcitonin, estimated glomerular filtration rate (eGFR), C-reactive protein, % lymphocyte, ferritin, aspartate aminotransferase, lactate dehydrogenase, alanine aminotransferase, creatine kinase, hemoglobin A1c, prothrombin time, activated partial prothrombin time (APTT), white blood cell count and creatinine] differed by illness severity.
Outcomes: All CT parameters and all blood take a look at parameters besides procalcitonin and APPT have been considerably totally different amongst delicate, reasonable and extreme teams. By multivariate evaluation, imply HU whole and eGFR have been two impartial elements related to severity (p < 0.0001). Cutoff values for imply HU whole and eGFR have been, respectively, – 801 HU and 77 ml/min/1.73 m2 between delicate and reasonable pneumonia and – 704 HU and 53 ml/min/1.73 m2 between reasonable and extreme pneumonia.
Conclusion: The imply HU whole of the entire lung, decided by the AI algorithm, and eGFR replicate the severity of COVID-19 pneumonia.
Frequency of optimistic anti-PF4/polyanion antibody checks after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2
Vaccination utilizing the adenoviral vector COVID-19 vaccine ChAdOx1 nCoV-19 (AstraZeneca) has been related to uncommon vaccine-induced immune thrombotic thrombocytopenia (VITT). Affected sufferers take a look at strongly optimistic in PF4/polyanion enzyme immunoassays (EIAs) and serum-induced platelet activation is maximal within the presence of PF4.
We decided the frequency of anti-PF4/polyanion antibodies in wholesome vaccinees and assessed whether or not PF4/polyanion EIA-positive sera exhibit platelet-activating properties after vaccination with ChAdOx1 nCoV-19 (n=138) or BNT162b2 (BioNTech/Pfizer; n=143). In whole, 19 of 281 contributors examined optimistic for anti-PF4/polyanion antibodies post-vaccination (All: 6.8% [95%CI, 4.4-10.3]; BNT162b2: 5.6% [95%CI, 2.9-10.7]; ChAdOx1 nCoV-19: 8.0% [95%CI, 4.5-13.7%]).
Optical densities have been largely low (between 0.5-1.Zero items; reference vary, <0.50) and not one of the PF4/polyanion EIA-positive samples induced platelet activation within the presence of PF4. We conclude that optimistic PF4/polyanion EIAs can happen after SARS-CoV-2 vaccination with each mRNA- and adenoviral vector-based vaccines, however the majority of those antibodies seemingly have minor (if any) medical relevance.
Accordingly, low-titer optimistic PF4/polyanion EIA outcomes needs to be interpreted with warning when screening asymptomatic people after vaccination in opposition to Covid-19. Pathogenic platelet-activating antibodies that trigger VITT don’t happen generally following vaccination.
s-xe
s-xe

anti- Galectin-1 antibody

FNab03315 100µg
EUR 658.5
Description: Antibody raised against Galectin-1

Human Galectin-1 (Gal-1) Antibody

30005-05111 150 ug
EUR 215

Human Galectin-1 (LGALS1)

1-CSB-EP012882HU
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli

Human Galectin-1 (LGALS1)

1-CSB-EP012882HUb1
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli

Human Galectin-3(Galectin-3)ELISA Kit

YLA0216HU-48T 48T Ask for price

Human Galectin-3(Galectin-3)ELISA Kit

YLA0216HU-96T 96T Ask for price

human anti-human galectin-3 mAb(2D)

E4A09H10-2D 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human galectin-3 mAb(5F)

E4A09H10-5F 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human galectin-3 mAb(A5)

E4A09H10-A5 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human galectin-3 mAb(G2)

E4A09H10-G2 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human galectin-3 mAb(H3)

E4A09H10-H3 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human galectin-3 mAb(T1)

E4A09H10-T1 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human galectin-3 mAb(N13)

E4A09H10-N13 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Anti Human Galectin-3 Polyclonal Antibody

KH040 each
EUR 778.8
Description: The Anti Human Galectin-3 Polyclonal Antibody is available in Europe and for worldwide shipping via Gentaur.

Recombinant Human Galectin-1

7-00427 10µg Ask for price

Recombinant Human Galectin-1

7-00428 50µg Ask for price

Recombinant Human Galectin-1

7-00429 1mg Ask for price

Recombinant Human Galectin-1

AP60482 100ug
EUR 449

Recombinant Human Galectin-1

HEOPP-0710 10ug Ask for price

RECOMBINANT HUMAN GALECTIN-1

GWB-BEA2B0 0.05 mg Ask for price

Recombinant Human Galectin-1

cyt-544-10g 10µg
EUR 60

Recombinant Human Galectin-1

cyt-544-1mg 1mg
EUR 1350

Recombinant Human Galectin-1

cyt-544-50g 50µg
EUR 145

Human Galectin 1 Protein

20-abx066725
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human Galectin-1 Antibody Pair Set

ABPR-ZB244 5 plates, 15 plates Ask for price
Description: Quantitative determination of Human Galectin-1

Galectin-1, human recombinant

4648-10 each
EUR 170.4

Galectin-1, human recombinant

4648-1000 each
EUR 1977.6

Galectin-1, human recombinant

4648-50 each
EUR 314.4

Galectin-1 Human Recombinant

rAP-2252 Inquiry Ask for price

Human Galectin-1 ELISA Kit

EK5323 96 tests
EUR 599

Human Galectin-1 ELISA Kit

IHULGALS1KT each
EUR 702
Description: Human Galectin-1 ELISA Kit

Mouse Monoclonal anti-human Galectin-1

hAP-1228 50ug
EUR 400

Sheep Polyclonal anti-Human Galectin-1

hAP-5905 50ug
EUR 400

Anti-Mouse Galectin-1 Antibody

103-M223 100 µg
EUR 399
Description: The galectins constitute a large family of carbohydrate-binding proteins that function in many systems both intracellularly and following secretion. Galectins contain either one or two carbohydrate recognition domains (CRR) which mediate recognition of N-acetyl-lactosamine-containing glycoproteins. Some galectins exist in multiple isoforms due to alternative splicing. Individual galectins differ in their tissue distribution and in their carbohydrate-binding specificities.

Human Galectin-1 (LEG1) Protein

abx690252-100g 100 µg
EUR 837.5

Human Galectin-1 (LEG1) Protein

abx690252-20g 20 µg
EUR 350

Human Galectin 1 (GAL1) ELISA

KT-15605 96 tests
EUR 952

Human Galectin-1 (LGALS1) Protein

abx670211-50ug 50 ug
EUR 661.2

Human Galectin 1 ELISA kit

E01A4669 96T
EUR 700
Description: ELISA

Human Galectin 1 ELISA kit

E01G0038-192T 192 tests
EUR 1524
Description: A sandwich ELISA for quantitative measurement of Human Galectin 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Galectin 1 ELISA kit

E01G0038-48 1 plate of 48 wells
EUR 624
Description: A sandwich ELISA for quantitative measurement of Human Galectin 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Galectin 1 ELISA kit

E01G0038-96 1 plate of 96 wells
EUR 822
Description: A sandwich ELISA for quantitative measurement of Human Galectin 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Galectin 1 ELISA Kit

IHUGAL1KT each
EUR 667
Description: Human Galectin 1 ELISA Kit

Galectin-10, Human

E34M155H 5 μg
EUR 155

Galectin-12, Human

E34M156H 5 μg
EUR 155

Galectin-13, Human

E34M157H 5 μg
EUR 155

Galectin-14, Human

E34M158H 5 μg
EUR 155

Galectin-16, Human

E34M159H 5 μg
EUR 155

Galectin-2, Human

E34M149H 5 μg
EUR 155

Galectin-3, Human

E34M150H 5 μg
EUR 155

Galectin-4, Human

E34M151H 5 μg
EUR 155

Galectin-7, Human

E34M152H 5 μg
EUR 155

Galectin-8, Human

E34M153H 5 μg
EUR 155

Galectin-9, Human

E34M154H 5 μg
EUR 155

Galectin-3 Human

GWB-1FDCC0 0.05 mg Ask for price

Anti-Human Galectin-3 Antibody

101-M424 100 µg
EUR 399
Description: The galectins constitute a large family of carbohydrate-binding proteins that function in many systems both intracellularly and following secretion. Galectins contain either one or two carbohydrate recognition domains (CRR) which mediate recognition of N-acetyl-lactosamine-containing glycoproteins. Some galectins exist in multiple isoforms due to alternative splicing. Individual galectins differ in their tissue distribution and in their carbohydrate-binding specificities.

Anti-Human Galectin-4 Antibody

101-M425 100 µg
EUR 399
Description: Galectin-4 is a member of the subfamily of galectins composed of two carbohydrate recognition domains having similar peptide chains. The galectins are a family of beta-galactoside-binding proteins having a role in modulating cell-cell and cell-matrix interactions, which inhibits chronic inflammations, GVHD, and allergic responses. LGALS4 expression is limited to small intestine, colon, and rectum, and it is underexpressed in colorectal cancer. LGALS4 binds as an endogenous ligand to glycosphingolipids having 3-O-sulfated Gal residues and bind as well to cholesterol-3-sulfate. LGALS4 takes part in cell adhesion. LGALS4 plays a role in crosslinking the lateral cell membranes of the surface-lining epithelial cells, thus supporting epithelial integrity against mechanical stress exerted by the bowel lume.

Anti-Human Galectin-8 Antibody

101-M427 100 µg
EUR 399
Description: LGALS8 is a prostate-specific antigen that is solely overexpressed in malignant tumors and thus is a supplementary specific identifier of malignancies. LGALS8 is part of the galectin gene family which facilitates both cell-cell and cell matrix interactions in a method parallel to the selectin subgroup of C-type lectins.

Anti-Human Galectin-3 Antibody

101-M747 100 µg
EUR 399
Description: The galectins constitute a large family of carbohydrate-binding proteins that function in many systems both intracellularly and following secretion. Galectins contain either one or two carbohydrate recognition domains (CRR) which mediate recognition of N-acetyl-lactosamine-containing glycoproteins. Some galectins exist in multiple isoforms due to alternative splicing. Individual galectins differ in their tissue distribution and in their carbohydrate-binding specificities.

Anti-Human Galectin-7 Antibody

101-M748 100 µg
EUR 399
Description: Galectin-7 is a protein that in humans is encoded by the LGALS7 gene. The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell–cell and cell–matrix interactions. Differential and in situ hybridizations indicate that this lectin is specifically expressed in keratinocytes. It is expressed at all stages of epidermal differentiation (i.e., in basal and supra-basal layers). It is moderately repressed by retinoic acid. The protein was found mainly in stratified squamous epithelium. The antigen localized to basal keratinocytes, although it was also found, albeit at lower levels, in the supra-basal layers where it concentrated to areas of cell-to-cell contact. The cellular localization and it’s striking down-regulation in cultured keratinocytes imply a role in cell–cell and/or cell–matrix interactions necessary for normal growth control.

Anti-Human Galectin-3 Antibody

102-P228 100 µg
EUR 245.7
Description: The galectins constitute a large family of carbohydrate-binding proteins that function in many systems both intracellularly and following secretion. Galectins contain either one or two carbohydrate recognition domains (CRR) which mediate recognition of N-acetyl-lactosamine-containing glycoproteins. Some galectins exist in multiple isoforms due to alternative splicing. Individual galectins differ in their tissue distribution and in their carbohydrate-binding specificities.

anti-human Galectin-3 antibody

10-2887 250 ug
EUR 410
Description: Purified anti-human Galectin-3 antibody

Anti-human Galectin-3 antibody

STJ15100163 250 µg
EUR 403.2
Description: This monoclonal antibody is for studies of antigen expression in cells and tissue sections using immunocytochemistry and immunoprecipitation

Recombinant Human Galectin-1(LGALS1)

AP70493 1mg
EUR 1978

Recombinant Human Galectin-1 (LGALS1)

CSB-EP012882HU 1598 mg Ask for price

Recombinant Human Galectin-1 (LGALS1)

CSB-EP012882HUb1 1599 mg Ask for price

Recombinant Human Galectin-1 (LGALS1)

Z101845 15 µg
EUR 105
Description: Galectin-1 is a member of the galectin family, and binds B-galactosidase moieties on glycoproteins or glycolipids. Galectins are primarily involved in modulation of cell-cell and cell-matrix interactions. Galectin-1 acts as a negative regulator of immunity, promoting immune suppression and lessening the inflammatory response. Galectin-1 binds CD45, CD3 and CD4, resulting in the inhibition of CD45 phosphatase dependant dephosphorylation of lyn kinase, as well as a number of other immune related receptors. Due to its function as a negative regulator of the immune response, and role inducing apoptosis in activated Th1 and Th17 cells, it is commonly found upregulated around malignant tumours. It has also been implicated as having a role in the development of immune tolerance during pregnancy, and is highly expressed at the maternal-fetal interface. As a dimer it down-regulates neutrophils by inducing exposure of phosphatidylserine, thereby marking the cell for apoptosis. It shares approximately 88% and 90% sequence similarity with mouse and rat galectin-1, respectively. Recombinant Human Galectin-1 is a 14.9kDa protein.

Recombinant Human Galectin-1 (LGALS1)

Z101847 100 µg
EUR 270
Description: Galectin-1 is a member of the galectin family, and binds B-galactosidase moieties on glycoproteins or glycolipids. Galectins are primarily involved in modulation of cell-cell and cell-matrix interactions. Galectin-1 acts as a negative regulator of immunity, promoting immune suppression and lessening the inflammatory response. Galectin-1 binds CD45, CD3 and CD4, resulting in the inhibition of CD45 phosphatase dependant dephosphorylation of lyn kinase, as well as a number of other immune related receptors. Due to its function as a negative regulator of the immune response, and role inducing apoptosis in activated Th1 and Th17 cells, it is commonly found upregulated around malignant tumours. It has also been implicated as having a role in the development of immune tolerance during pregnancy, and is highly expressed at the maternal-fetal interface. As a dimer it down-regulates neutrophils by inducing exposure of phosphatidylserine, thereby marking the cell for apoptosis. It shares approximately 88% and 90% sequence similarity with mouse and rat galectin-1, respectively. Recombinant Human Galectin-1 is a 14.9kDa protein.

Recombinant Human Galectin-1 (LGALS1)

Z101849 1.0 mg
EUR 1135
Description: Galectin-1 is a member of the galectin family, and binds B-galactosidase moieties on glycoproteins or glycolipids. Galectins are primarily involved in modulation of cell-cell and cell-matrix interactions. Galectin-1 acts as a negative regulator of immunity, promoting immune suppression and lessening the inflammatory response. Galectin-1 binds CD45, CD3 and CD4, resulting in the inhibition of CD45 phosphatase dependant dephosphorylation of lyn kinase, as well as a number of other immune related receptors. Due to its function as a negative regulator of the immune response, and role inducing apoptosis in activated Th1 and Th17 cells, it is commonly found upregulated around malignant tumours. It has also been implicated as having a role in the development of immune tolerance during pregnancy, and is highly expressed at the maternal-fetal interface. As a dimer it down-regulates neutrophils by inducing exposure of phosphatidylserine, thereby marking the cell for apoptosis. It shares approximately 88% and 90% sequence similarity with mouse and rat galectin-1, respectively. Recombinant Human Galectin-1 is a 14.9kDa protein.

Human Galectin-1 ELISA ELISA Kit

E16HE0311 96T
EUR 1000

Human Galectin-1 Recombinant Protein

100-175 50 µg
EUR 196.35
Description: Lectins, of either plant or animal origin, are carbohydrate binding proteins that interact with glycoprotein and glycolipids on the surface of animal cells. The Galectins are lectins that recognize and interact with β-galactoside moieties. Galectin-1 is an animal lectin that has been shown to interact with CD3, CD4, and CD45. It induces apoptosis of activated T-cells and T-leukemia cell lines and inhibits the protein phosphatase activity of CD45. Recombinant human Galectin-1 is a 14.5 kDa protein containing 134 amino acid residues.

Human Galectin-1 Recombinant Protein

100-175S 10 µg
EUR 92.4
Description: Lectins, of either plant or animal origin, are carbohydrate binding proteins that interact with glycoprotein and glycolipids on the surface of animal cells. The Galectins are lectins that recognize and interact with β-galactoside moieties. Galectin-1 is an animal lectin that has been shown to interact with CD3, CD4, and CD45. It induces apoptosis of activated T-cells and T-leukemia cell lines and inhibits the protein phosphatase activity of CD45. Recombinant human Galectin-1 is a 14.5 kDa protein containing 134 amino acid residues.

Human Galectin-1 Recombinant Protein

400-015 50 µg
EUR 126
Description: Lectins, of either plant or animal origin, are carbohydrate binding proteins that interact with glycoprotein and glycolipids on the surface of animal cells. The Galectins are lectins that recognize and interact with beta-galactoside moieties. Galectin-1 is an animal lectin that has been shown to interact with CD3, CD4, and CD45. It induces apoptosis of activated T-cells and T-leukemia cell lines and inhibits the protein phosphatase activity of CD45. Recombinant human Galectin-1 is a 14.5 kDa protein containing 134 amino acid residues.

Recombinant Human Galectin-1 Protein

E40KMP1041 20ug
EUR 495

Recombinant Human Galectin-1 Protein

PROTP09382-1 50ug
EUR 380.4
Description: Lectins, of either plant or animal origin, are carbohydrate binding proteins that interact with glycoprotein and glycolipids on the surface of animal cells. The Galectins are lectins that recognize and interact with β-galactoside moieties. Galectin-1 is an animal lectin that has been shown to interact with CD3, CD4, and CD45. It induces apoptosis of activated T-cells and T-leukemia cell lines and inhibits the protein phosphatase activity of CD45. Recombinant human Galectin-1 is a 14.5 kDa protein containing 134 amino acid residues.

Human Galectin 10 Antibody

32652-05111 150 ug
EUR 215

Human Galectin 8 Antibody

33159-05111 150 ug
EUR 215

Human Galectin 2 Antibody

33165-05111 150 ug
EUR 215

Human Galectin 13 Antibody

33175-05111 150 ug
EUR 215

Human Galectin 1 (LGALS1) Protein

abx066725-100g 100 µg
EUR 512.5

Human Galectin 1 (LGALS1) Protein

abx066725-10g 10 µg
EUR 212.5

Human Galectin 1 (LGALS1) Protein

abx066725-50g 50 µg
EUR 362.5

Human Galectin 1 (LGALS1) Protein

abx670211-100g 100 µg
EUR 450

Human Galectin-1(LGALS1) ELISA kit

E01A4871 96T
EUR 700
Description: ELISA

Human Galectin-1(LGALS1) ELISA kit

E01G0448-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Human Galectin-1(LGALS1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Galectin-1(LGALS1) ELISA kit

E01G0448-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Human Galectin-1(LGALS1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Galectin-1(LGALS1) ELISA kit

E01G0448-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human Galectin-1(LGALS1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Galectin-1(LGALS1) ELISA kit

EKC33776-48T 48T
EUR 535.99

Human Galectin-1(LGALS1) ELISA kit

EKC33776-5x96T 5x96T
EUR 3637.08

Human Galectin-1(LGALS1) ELISA kit

EKC33776-96T 96T
EUR 765.7

Covid-19 antigen take a look ating: higher than we all know? A take a look at accuracy research

Background: Antigen testing for SARS-CoV-2 is taken into account to be much less delicate than the usual reference methodology – real-time PCR (RT-PCR). It has been steered that many sufferers with optimistic RT-PCR ‘missed’ by antigen testing could be non-infectious.
Strategies: In a real-world high-throughput setting for asymptomatic or mildly symptomatic sufferers, 494 sufferers have been examined utilizing RT-PCR in addition to a single lateral movement antigen take a look at (Ecotest, AssureTech, China). The place the outcomes differed, virus viability was evaluated by cell tradition. The take a look at parameters have been calculated with RT-PCR and RT-PCR adjusted on viability as reference requirements.
Outcomes: The general sensitivity of the used antigen take a look at associated to the RT-PCR solely was 76.2%, specificity was 97.3%. Nonetheless, 36 out of 39 sufferers ‘missed’ by the antigen take a look at contained no viable virus. After adjusting on that, the sensitivity grew to 97.7% and, extra importantly for illness management functions, the unfavorable predictive worth reached 99.2%.
Conclusions: We suggest that viability testing needs to be all the time carried out when evaluating a brand new antigen take a look at. A well-chosen and validated antigen take a look at gives glorious leads to figuring out sufferers who’re shedding viable virus (though some caveats nonetheless stay) within the real-world high-throughput setting of asymptomatic or mildly symptomatic people.

Extended Optimistic COVID-19 Check in Recovered Affected person

Coronavirus illness 2019 (COVID-19), brought on by the novel extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a world pandemic that has affected hundreds of thousands worldwide since its preliminary outbreak in Wuhan, China in December 2019. Dialogue of atypical instances of COVID-19 is crucial to gaining perception into the medical displays of this an infection.
The authors report a case wherein a 74-year-old feminine who sought medical analysis by way of telemedicine for chief complaints of recurrent low-grade fever, dyspnea, dry cough, and myalgias and subsequently examined optimistic for the SARS-CoV-2 a number of occasions in over 7 weeks regardless of prior decision of signs. The affected person’s 78-year-old husband who resides in the identical family additionally contracted the SARS-CoV-2.

Antibody (Serology) Assessments for COVID-19: a Case Research

Serology (antibody) checks to detect earlier SARS-CoV-2 an infection have been in excessive demand from the start of the COVID-19 pandemic. The preliminary scarcity of diagnostic checks coupled with asymptomatic infections led to a major demand for serology checks to establish previous infections.
Regardless of critical limitations on the interpretation of a optimistic antibody take a look at by way of immunity to SARS-CoV-2, antibody testing was initially thought-about for launch from social distancing, return to employment, and “immunity passports.”
The regulatory strategy to antibody checks was restricted; producers have been inspired to develop and market antibody checks with out submitting validation information to the FDA. FDA steering grew extra stringent, however many poor-quality checks have been already on the market-potentially inappropriately used for particular person decision-making. This can be a case research describing COVID-19 serology checks and the U.S. market and describes classes discovered for a future well being safety disaster.

Add a Comment

Your email address will not be published. Required fields are marked *